K. Kawano

Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma: A Japan Clinical Oncology Group Study, JCOG 9301

M. Tomonaga, A. Utsunomiya, K. Itoh, 2004, International journal of hematology.